Chris Lange

Chris Lange is an analyst for 24/7 Wall St., based in Houston. He has covered financial markets over the past five years with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and has helped start a small business.

Lastest Stories by Chris Lange

Investors Cheer AnPac Bio's Coronavirus Developments
AnPac Bio-Medical Science shares surged higher on Friday after the company reaffirmed its status as a COVID-19 stock.
Chris Lange
15 hours ago

Why Conduent Is Friday's Big Earnings Winner
Conduent stock rallied after the company reported better than expected second-quarter financial results late Thursday.
Chris Lange
15 hours ago

Is Groupon Back After Explosive Q2?
Groupon stock rallied Friday morning after the online marketplace provider reported better than expected second-quarter financial results late Thursday.
Chris Lange
16 hours ago

Is Uber Now a Delivery Company After This Quarter?
Ride-sharing giant Uber reported second-quarter financial results after markets closed Thursday. The company posted a net loss of $1.02 per share and $2.24 billion in revenue compared with consensus...
Chris Lange
1 day ago

Rocket Mortgage and Quicken Loans Parent Quietly Enters the Market
Rocket Companies, parent of Rocket Mortgage and Quicken Loans, quietly entered the market on Thursday in its initial public offering.
Chris Lange
1 day ago
Last Updated: 1 day ago

Denali Therapeutics Takes Next Big Step in Treating Parkinson's
Denali Therapeutics announced early Thursday that it would be progressing its Parkinson’s treatment into late-stage studies in collaboration with Biogen.
Chris Lange
1 day ago

How Plug Power's Rosy Outlook and Acquisitions Played Into an All-Around Solid Q2
Plug Power released a better than expected second-quarter earnings report before the markets opened on Thursday, and shares shot up afterward.
Chris Lange
1 day ago

Etsy Earnings: When Incredible Isn't Good Enough
Etsy shares sank early Thursday even though it reported better than expected second-quarter financial results after the markets closed on Wednesday.
Chris Lange
1 day ago

Why Roku's Q2 Report Is So Great
Streaming video firm Roku reported a second-quarter net loss of $0.35 per share and $356 million in revenue compared to consensus estimates calling for a net loss of $0.50 per share and $315 million...
Chris Lange
2 days ago

Rackspace's IPO Is Severely Underwhelming
End-to-end multicloud technology services company Rackspace Technology entered the market with a whimper.
Chris Lange
2 days ago

Novavax Bulls Keep Charging as More COVID-19 Results Come Out
Novavax shares hit another all-time high on Wednesday after the company announced positive results from its early stage COVID-19 vaccine study.
Chris Lange
2 days ago

Key Apple Analyst Downgrade Not Just About Stock Price
Many see Apple stock going nowhere but up. See why Wamsi Mohan at BofA Securities has downgraded the stock but increased the price target.
Chris Lange
2 days ago

Which Segment Dragged on Beyond Meat in Q2?
Beyond Meat reported its most recent quarterly results after the markets closed on Tuesday, and shares retreated early Wednesday.
Chris Lange
2 days ago

5 Large Biotech and Pharma Stocks Are Dirt Cheap, and Not Because of COVID-19
24/7 has compiled a few biopharmaceutical names that have lagged the markets and recently have reported earnings. In a sense, the fundamentals have shown some light on these stocks, that they may be...
Chris Lange
2 days ago
Last Updated: 2 days ago

What's Driving Nikola Stock Down in Q2
Electric/hydrogen-powered truck builder Nikola reported a second-quarter net loss of $0.16 per share and $36,000 in revenue. Analysts were calling for a net loss of $0.13 per share and only $20,000...
Chris Lange
3 days ago